Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2023 08:47 ET | Source: Neuronetics

Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR

MALVERN, Pa., May 08, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
May 05, 2023 08:30 ET | Source: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., May 05, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
May 03, 2023 08:58 ET | Source: Neuronetics

Neuronetics Showcases New NeuroStar® TMS Findings at Clinical TMS Society Annual Meeting

MALVERN, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
May 02, 2023 09:01 ET | Source: Neuronetics

NeuroStar® Expands “Tap Into Possibility” Campaign in Honor of Mental Health Awareness Month

A Media Snippet accompanying this announcement is available by clicking on the image or link below: MALVERN, Pa., May 02, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial...
May 01, 2023 08:46 ET | Source: Neuronetics

Neuronetics Announces Lisa Metzner-Rosas as SVP, Chief Marketing Officer

MALVERN, Pa., May 01, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
April 28, 2023 16:11 ET | Source: Neuronetics

Neuronetics Announces Expanded TMS Access through United HealthCare

MALVERN, Pa., April 28, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
April 25, 2023 08:30 ET | Source: Neuronetics

Neuronetics to Report First Quarter 2023 Financial and Operating Results and Host Conference Call

MALVERN, Pa., April 25, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
April 13, 2023 08:58 ET | Source: Neuronetics

Neuronetics Announces Continued Momentum for Expanded Health Insurance Coverage for TMS Therapy

MALVERN, Pa., April 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
April 06, 2023 16:16 ET | Source: Neuronetics

NeuroStar® Advanced Therapy Enhanced With Wi-Fi Capabilities

MALVERN, Pa., April 06, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
April 04, 2023 08:30 ET | Source: Neuronetics

Neuronetics Secures Up To $60 Million in New Debt Financing with SLR Capital Partners, Provides Greenbrook TMS with $6.0 Million Promissory Note

MALVERN, Pa., April 04, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right